Medtronic (NYSE:MDT) recently reported its Q4 fiscal 2019 results, which were above our estimates, led by the Restorative Therapies Group. This note details the company's Q4 performance, and Trefis' forecasts for the full fiscal 2020. You can view our interactive dashboard analysis ~ How Did Medt...